Serval studies have revealed that GzmB-producing regulatory B cells are decreased in peripheral blood of systemic lupus erythematosus (SLE), lupus nephritis, and rheumatoid arthritis (RA), which are closely associated with poor prognosis of these diseases (32–34). This evidence concerns the gene GZMB and rheumatoid arthritis.